neurology

News

AZ to develop Parkinson's drug with Takeda

AstraZeneca could receive up to $400 million from Takeda after approaching the company to jointly develop and market a new treatment for Parkinson’s disease (PD).

News

GW prepares for 2018 US launch of epilepsy drug

But Zynerba's cannabis epilepsy drug fails in phase 2.

News

doctor is sending result of medical test to patient on tablet computer

Brain training app reduces symptoms of pre-dementia

App improves episodic memory by 40%.

News

A sad young woman is sitting in her kitchen with a headache

Alder shares slump despite migraine success

Investors concerned over strong placebo effect

News

UK patients gain early access to Duchenne drug

Patients to get Santhera's Raxone under EAMS scheme.

News

Shire long-acting ADHD drug finally approved

Mydadis approval ends decade-long saga with FDA.

AZ to develop Parkinson's drug with Takeda

GW prepares for 2018 US launch of epilepsy drug

Brain training app reduces symptoms of pre-dementia

Alder shares slump despite migraine success

UK patients gain early access to Duchenne drug

Shire long-acting ADHD drug finally approved

GBL joins CVC in €10.7bn takeover bid for Recordati

Discover a new era of healthcare panel engagement: Grounded ...

neurology

Editor's Picks